Announcements

Peter Barton Hutt, Angels for Change, and City of Hope to Receive 2026 Innovations in Regulatory Science & Policy Awards
The Reagan-Udall Foundation for the FDA will recognize the late Peter Barton Hutt, Angels for Change, and City of Hope at its 10th annual Innovations in Regulatory Science & Policy Awards on December 8, 2026. The awards honor contributions to…
Read More
The Foundation’s Role in Advancing Medical Product Development in the United States
Read More
Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development Written Testimony
Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development Written Testimony
Read More
More Announcements

Coverage

Imperatives for United States Clinical Research Leadership and Coordination
The United States spends nearly 18 percent of its gross domestic product on health care, yet health outcomes continue to lag behind those of peer nations, even as US leadership in life sciences faces growing global competition. This report argues that…
Read More
FDA Launches Rare Disease Framework Initiative to Modernize Small-Cohort Trial Design
To begin shaping the detailed regulations, revised guidances, and internal reviewer training modules, the FDA will convene a major public stakeholder summit on October 28 at its White Oak headquarters in Silver Spring, Maryland, facilitated by the…
Read More
Special Seminar: An Interactive Session Offering Expert Insight on Engaging Potential Research Support
As an appointee to the board of the FDA’s Reagan-Udall Foundation, Ed joins a high-profile list of life sciences leaders including former FDA Commissioners, global biotech executives and CMS health policy administrators.
Read More
More Coverage